He actually spent about 6 months doing due diligence on the product, checking out the prospects of the company, it had nothing to do with just putting money in to help the chairman as you suggest. Peter Corr deals with billion dollar investments ,he would not be in this for a few points as you suggest.What the company is waiting for is a licensing deal not clinical trials as you suggest, this is why Corr got involved. So please do some research before you make such uninformed comments !!!
ALT Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
